ASCIL Biopharm is a Drug Delivery Systems (DDS) company focused on research and development of formulations and medical devices with innovative solutions to enhance efficacy, safety and patient outcomes.
Expertise
Controlled Release Formulations
for systemic delivery. High dose & high concentration.
Controlled Release Formulations for locoregional delivery. Small dose & high concentration.
Precision Medical Devices
for liquid, viscous and solid injectables.
Ascil Biopharm Parc Tecnològic del Vallès Av. Universitat Autonoma 1
08290 Cerdanyola del Valles
Barcelona, Spain
info@ascil-biopharm.com
We are settled in a 1500 m2 building fully equipped for pharmaceutical development. A GMP facility which includes laboratories and a pilot plant for technical and clinical batches (parenteral products).
Resolució EMC/1845/2016 d’11 de juliol (DOGC núm. 7172 de 28.7.2106) de convocatòria de la línia d’ajuts aNUCLIS DE RECERCA INDUSTRIAL I DESENVOLUPAMENT EXPERIMENTAL, enregistrada amb el número d’expedient RD16-1-0030 que s’atorga al projecteDISPOSITIU MÈDIC BIODEGRADABLE COM A EINA DE MILLORA TERAPÈUTICA EN MALALTIA DE LLARGA DURADA. Aquest projecte ha estat cofinançat per la Unió Europea a través del Fons Europeu de Desenvolupament Regional (FEDER). Amb la col·laboració d’ACCIÓ.
Medical Device
Resolution EMC/1845/2016 dated 11th of July (DOGC number 7172 de 28.7.2106) regarding the call for aids in NUCLEUS OF INDUSTRIAL RESEARCH AND EXPERIMENTAL DEVELOPMENT registered with the expedient number RD16-1-0030 to grant the project BIODEGRADABLE MEDICAL DEVICE AS A TOOL FOR THERAPEUTIC IMPROVEMENT IN A LONG-TERM ILLNESS. This project has received funding from the European Union through the European Regional Development Fund (ERDF). With the collaboration from ACCIO.